Business
Cannara Biotech Receives Sales Licence from Health Canada
Cannara Biotech Receives Sales Licence from Health Canada Canada NewsWire ...
About this update from Cannara Biotech, Inc.
[{"type":"text","content":"\n \n \n \n Cannara Biotech Receives Sales Licence from Health Canada\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n Cannara to start delivering cannabis products to the Société québécoise du cannabis (SQDC) under its existing Letter of Intent.\n \n \n \n \n MONTREAL\n \n ,\n \n Jan. 8, 2021\n \n /CNW/ - Cannara Biotech Inc.(\"Cannara\" or the \"Company\") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is pleased to announce that, through its wholly-owned subsidiary, Cannara Biotech (\n \n Quebec\n \n ) Inc., it has received approval from Health Canada to amend its license to permit the sale of dried cannabis products to provincially authorized distributors and retailers nationwide. As revenue steadily grows over the next 12 months, Cannara expects rapid growth in profitability and cashflow given its lean operating structure and production cost advantage.\n \n \n \n \n \n \n \n \n \n \"Within our home province of\n \n Quebec\n \n , demand for high quality\n \n Quebec\n \n -grown cannabis is strong and expanding rapidly,\" said Zohar Krivorot, President and Chief Executive Officer of Cannara. \"The receipt of our sales licence from Health Canada is a significant milestone in our journey and will enable us to continue executing our plan to generate value for consumers and shareholders. We look forward to getting our brand portfolio into the hands of customers across the province of\n \n Quebec\n \n over the coming months.\"\n \n \n \n Cannara products\n \n \n Cannara indoor-grown cannabis is produced to the highest quality standards. As a result cannabis is cultivated from a bank of rare genetics, hang-dried, slow-cured, and hand-trimmed. The Company plans to initially launch three product lines:\n \n \n \n \n THC-dominant:\n \n Top-shelf genetics featuring hand-crafted cannabis with elevated THC and rich terpene profiles, available in 3.5 gram and pre-roll formats.\n \n \n \n CBD-dominant:\n \n Unique genetics containing less THC and more CBD available in 3.5 gram and pre-roll formats.\n \n \n \n High-value:\n \n Qu...